Ricardo Zwirtes

Company: Daiichi Sankyo, Inc.

Job title: Executive Director, Global Clinical Lead

Seminars:

TROP2 ADC Development: Exploring the Datopotamab Deruxtecan Mechanism, Clinical Efficacy, & Future Directions 8:00 am

Delving into the intricacies of Dato-DXd mechanism of action and the innovative approach in developing ADCs with the DXd linker-payload technology Examining the comprehensive late-stage clinical data for Dato-DXd, highlighting its clinical efficacy and safety profile Discussing the critical insights gained from the development of Dato-DXd, and outline the strategic next steps for its clinical…Read more

day: Day One AM